Differentiated Thyroid Carcinoma
Conditions
Interventions
Experimental group:WMA+131I therapy
The control group:131I therapy
Sponsors
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with differentiated thyroid cancer underwent total thyroidectomy and a cervical lymph nodes dissection; 2. All patients were confirmed by biopsy pathology as cervical lymph nodes metastasis after operation of differentiated thyroid carcinoma; 3. Recurrent patients are unsuitable or refuse surgical treatment due to high surgical risk or other reasons.
Exclusion criteria
Exclusion criteria: 1. Pregnant; 2. Patients with coagulation dysfunction with severe bleeding tendency; 3. Patients with severe dysfunction of multiple organs; 4. There is no appropriate puncture route on ultrasound; 5. There were serious contraindications to the treatment in our study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lymph nodes volume reduction rate; | — |
Countries
China
Contacts
Public ContactWang Bei
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Outcome results
None listed